Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1440
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America ; day:3 ; month:1 ; year:2021 ; pages:1-3
Journal of molecular medicine ; (3.1.2021), 1-3
- Urheber
-
Garneau, Alexandre P.
Haydock, Ludwig
Tremblay, Laurence E.
Isenring, Paul
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00109-020-02030-6
- URN
-
urn:nbn:de:101:1-2021020500263900455635
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Garneau, Alexandre P.
- Haydock, Ludwig
- Tremblay, Laurence E.
- Isenring, Paul
- SpringerLink (Online service)
Ähnliche Objekte (12)
Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?
Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G
PIK3CA-related overgrowth with an uncommon phenotype: case report
Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
Genetic basis and imaging findings of neurofibromatosis 1 and other somatic overgrowth disorders
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
Somatic mutation and gain of copy number of PIK3CA in human breast cancer
Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene
Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?
Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G
PIK3CA-related overgrowth with an uncommon phenotype: case report
Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
Genetic basis and imaging findings of neurofibromatosis 1 and other somatic overgrowth disorders
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
Somatic mutation and gain of copy number of PIK3CA in human breast cancer
Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene
Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?
Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G
PIK3CA-related overgrowth with an uncommon phenotype: case report
Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
Genetic basis and imaging findings of neurofibromatosis 1 and other somatic overgrowth disorders
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
Somatic mutation and gain of copy number of PIK3CA in human breast cancer